Genome-wide association study identifies zonisamide responsive gene in Parkinson’s disease patients

Tp53 gene mediates distinct dopaminergic neuronal damage in different dopaminergic neurotoxicant models

(2017) Yu Luo et al.   Neural Regeneration Research

Dopamine D2 receptor gene variants and response to rasagiline in early Parkinson’s disease: a pharmacogenetic study

(2016) Mario Masellis et al.   BRAIN

Dopaminergic neuron-specific deletion of p53 gene is neuroprotective in an experimental Parkinson's disease model

(2016) Xin Qi et al.   JOURNAL OF NEUROCHEMISTRY

Converging roles of ion channels, calcium, metabolic stress, and activity pattern ofSubstantia nigradopaminergic neurons in health and Parkinson's disease

(2016) Johanna Duda et al.   JOURNAL OF NEUROCHEMISTRY

Polymorphism of the dopamine transporter type 1 gene modifies the treatment response in Parkinson’s disease

(2015) Caroline Moreau et al.   BRAIN

Zonisamide reduces nigrostriatal dopaminergic neurodegeneration in a mouse genetic model of Parkinson's disease

(2015) Hiromi Sano et al.   JOURNAL OF NEUROCHEMISTRY

Zonisamide improves wearing-off in Parkinson's disease: A randomized, double-blind study

(2015) Miho Murata et al.   MOVEMENT DISORDERS

New treatments for levodopa-induced motor complications

(2015) Olivier Rascol et al.   MOVEMENT DISORDERS

A global reference for human genetic variation

(2015) Richard A. Gibbs et al.   NATURE

minimac2: faster genotype imputation

(2014) Christian Fuchsberger et al.   BIOINFORMATICS

VEGAS2: Software for More Flexible Gene-Based Testing

(2014) Aniket Mishra et al.   Twin Research and Human Genetics

Targeting GTPases in Parkinson’s disease: comparison to the historic path of kinase drug discovery and perspectives

(2014) Lin Hong et al.   Frontiers in Molecular Neuroscience

Current approaches to the treatment of Parkinson’s disease

(2011) Joseph Jankovic   Neuropsychiatric Disease and Treatment

LocusZoom: regional visualization of genome-wide association scan results

(2010) R. J. Pruim et al.   BIOINFORMATICS

Apoptosis in Parkinson's disease: Is p53 the missing link between genetic and sporadic Parkinsonism?

(2010) Cristine Alves da Costa et al.   CELLULAR SIGNALLING

Zonisamide: Aspects in neuroprotection

(2010) Thomas W. Rösler et al.   EXPERIMENTAL NEUROLOGY

GSA-SNP: a general approach for gene set analysis of polymorphisms

(2010) Dougu Nam et al.   NUCLEIC ACIDS RESEARCH

Neuroprotective effects of zonisamide target astrocyte

(2009) Masato Asanuma et al.   ANNALS OF NEUROLOGY

The antiepileptic drug zonisamide inhibits MAO-B and attenuates MPTP toxicity in mice: Clinical relevance

(2009) Patricia K. Sonsalla et al.   EXPERIMENTAL NEUROLOGY

Genome-wide association study identifies common variants at four loci as genetic risk factors for Parkinson's disease

(2009) Wataru Satake et al.   NATURE GENETICS

Zonisamide enhances delta receptor-associated neurotransmitter release in striato-pallidal pathway

(2009) S. Yamamura et al.   NEUROPHARMACOLOGY